CONNECTIVE TISSUE DISEASES Trial of SLE therapies in real-world settings

Manuel Ramos-Casals, Munther A. Khamashta

Research output: Contribution to journalEditorialpeer-review

2 Citations (Scopus)

Abstract

Allocation of therapy for systemic lupus erythematosus (SLE) remains complex, as most drugs used to treat this disease are used off-label-a situation compounded by the emergence of new therapeutics. In this rapidly changing clinical setting, organ-specific therapeutic guidelines might be useful for 'real world' management of patients with SLE.
Original languageEnglish
Pages (from-to)128 - 130
Number of pages3
JournalNature Reviews Rheumatology
Volume8
Issue number3
DOIs
Publication statusPublished - Mar 2012

Fingerprint

Dive into the research topics of 'CONNECTIVE TISSUE DISEASES Trial of SLE therapies in real-world settings'. Together they form a unique fingerprint.

Cite this